Initial bioinformatic analysis of scRNA-seq data showed that, compared with healthy donors, the striking increase of CD8+ effector T cells in the colon was obvious in checkpoint inhibition therapy treated melanoma patients with colitis. The gene discussed is CD8A; the disease is melanoma.